These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement. Ribeiro SL, Pereira HL, Silva NP, Neves RM, Sato EI. Braz J Med Biol Res; 2008 Nov 01; 41(11):1005-10. PubMed ID: 19099154 [Abstract] [Full Text] [Related]
13. The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years. da Mota LM, Dos Santos Neto LL, de Carvalho JF, Pereira IA, Burlingame R, Ménard HA, Laurindo IM. Rheumatol Int; 2012 Dec 01; 32(12):3807-12. PubMed ID: 22187055 [Abstract] [Full Text] [Related]
17. Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations. Korkmaz C, Us T, Kaşifoğlu T, Akgün Y. Clin Biochem; 2006 Oct 01; 39(10):961-5. PubMed ID: 16979149 [Abstract] [Full Text] [Related]
18. Analysis of four serum biomarkers in rheumatoid arthritis: association with extra articular manifestations in patients and arthralgia in relatives. Nass FR, Skare TL, Goeldner I, Nisihara R, Messias-Reason IT, Utiyama SRR. Rev Bras Reumatol Engl Ed; 2017 Oct 01; 57(4):286-293. PubMed ID: 28743354 [Abstract] [Full Text] [Related]
20. Association of anticyclic citrullinated peptide antibodies and/or rheumatoid factor status and clinical presentation in early arthritis: results from the ESPOIR cohort. Mouterde G, Lukas C, Goupille P, Flipo RM, Rincheval N, Daurès JP, Combe B. J Rheumatol; 2014 Aug 01; 41(8):1614-22. PubMed ID: 25028372 [Abstract] [Full Text] [Related] Page: [Next] [New Search]